P300/CBP-HAT-INHIBITOREN

European patent · EP3752497 · Deleted

Register entry

Publication number
EP3752497
Application number
EP19709182
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 15, 2019
Published
Dec 23, 2020
Granted
Jul 17, 2024
Deleted
Sep 23, 2026
Reason
Annual fee unpaid
IPC classes
C07D 401/14 (2006.01)
A61K 31/404 (2006.01)
A61K 31/415 (2006.01)
A61K 31/4164 (2006.01)
A61K 31/4439 (2006.01)
A61K 31/451 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/495 (2006.01)
A61K 31/50 (2006.01)
A61K 31/505 (2006.01)
A61K 31/506 (2006.01)
C07D 231/12 (2006.01)
C07D 233/64 (2006.01)
C07D 401/04 (2006.01)
C07D 403/04 (2006.01)
Priority
US 201862631596 P 16.02.2018
US 201862758885 P 12.11.2018
PCT application
PCT/US2019/018158 15.02.2019
PCT publication
WO2019/161162 22.08.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 23, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.09.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.09.2026

  2. May 28, 2025

    Change

    Published in Swissreg on 28.05.2025

  3. Mar 6, 2025

    Next annual fee due on

    Next annual fee due on
    28.02.2025 → 28.02.2026

    Published in Swissreg on 06.03.2025

  4. Jul 17, 2024

    Granted

    Published in Swissreg on 17.07.2024

Parties

Holder

Constellation Pharmaceuticals, Inc.

470 Atlantic Avenue, Suite 1401, Boston, MA 02210, US

Inventor

WILSON, Jonathan, E.

Arlington, MA 02474, US

LEVELL, Julian, R.

Arlington, MA 02474, US

BRUCELLE, Francois

Cambridge, MA 02142, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.